List of news related to Stocks with massive upside potential:

Title: Guggenheim Raises GeneDx (WGS) Price Target, Maintaining a Buy Rating
URL: https://finance.yahoo.com/news/guggenheim-raises-genedx-wgs-price-164358009.html
Time Published: 2025-07-03T16:43:58Z
Description: GeneDx Holdings Corp (NASDAQ:WGS) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Guggenheim analyst Subbu Nambi has raised the...
--------------------------------------------------

Title: Should You Invest in GE Aerospace (GE)?
URL: https://finance.yahoo.com/news/invest-ge-aerospace-ge-131703111.html
Time Published: 2025-07-03T13:17:03Z
Description: Rothschild & Co Wealth Management, an investment management company, released its LongRun Equity strategy first quarter 2025 investor letter. A copy of the...
--------------------------------------------------

Title: What Makes Cadence Design Systems (CDNS) an Investment Opportunity?
URL: https://finance.yahoo.com/news/makes-cadence-design-systems-cdns-131432972.html
Time Published: 2025-07-03T13:14:32Z
Description: Rothschild & Co Wealth Management, an investment management company, released its LongRun Equity strategy first quarter 2025 investor letter. A copy of the...
--------------------------------------------------

Title: BigBear.ai’s big question: Can a $1.9 billion company turn small investors into millionaires?
URL: https://economictimes.indiatimes.com/news/international/us/bigbear-ais-big-question-can-a-1-9-billion-company-turn-small-investors-into-millionaires/articleshow/122210120.cms
Time Published: 2025-07-02T16:58:41Z
Full Content:
(Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. (Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. Netanyahu vows to wipe out Hamas Melania faces fire over 'Einstein visa' FBI arrests two Chinese 'spies' HDB’s IPO test & Trump’s $3T bill Xiaomi YU7: Tesla slayer or a victim of its own hype? INS Tamal: India’s latest stealth upgrade Dalai Lama asserts sole power over reincarnation DOGE eats Musk?: Trump threatens contract review Mamdani hits back at Trump over arrest threat Trump says US could reach trade deal with India Hot on Web In Case you missed it Top Searched Companies Top Calculators Top Commodities Top Slideshow Top Prime Articles Private Companies Top Story Listing Top Definitions Top Market Pages Latest News Follow us on: Find this comment offensive? Choose your reason below and click on the Report button. This will alert our moderators to take action Reason for reporting: Your Reason has been Reported to the admin. Log In/Connect with: Will be displayed Will not be displayed Will be displayed Stories you might be interested in
--------------------------------------------------

Title: Arbitrum jumps 5% on Robinhood news – But THIS can ruin ARB’s breakout
URL: https://ambcrypto.com/?p=507423
Time Published: 2025-07-02T15:00:03Z
Full Content:
Robinhood’s ARB adoption, $2.2M outflows, and a chart breakout—will ARB hit $0.50 next? Arbitrum [ARB] surprised the market with a clean 5% rally at press time, standing out while other major altcoins struggled for direction. The reason? Robinhood’s announcement. AMBCrypto had earlier reported that Robinhood would launch tokenized stocks, ETFs, and equities for EU users using Arbitrum’s Layer 2, alongside future plans to build a custom Orbit-based chain. Naturally, the market interpreted this as a massive ecosystem endorsement—bullish for ARB. At press time, Arbitrum traded around $0.342, notching a 4.88% gain in the past 24 hours, per CoinMarketCap. While it led daily altcoin gainers, trading volume dropped nearly 30%, hinting at light participation behind the move. Despite lower participation from crypto investors, experts and analysts have shown strong interest in the token and appear to be making bold predictions. One expert emphasized that ARB is unlikely to miss its current level again, highlighting the asset’s strong upside potential. Meanwhile, another expert made a bold prediction, stating, “ARB is currently trading at $0.32 and showing strong momentum toward the $1 mark.” These are not the only posts that have surfaced on X; there are several other optimistic posts suggesting strong expert interest in the token and its upside potential. According to AMBCrypto’s technical analysis, the ARB coin has been hovering within a descending channel pattern between the upper and lower boundaries since May 2025. With the recent price jump, the altcoin appeared to be heading toward the upper boundary of the channel. Source: TradingView If this rally holds, ARB could stretch another 7% to retest the channel top near $0.37. Furthermore, if this momentum continues and ARB breaks out of the channel, there is a strong possibility the altcoin could see a price surge of up to 34% in the near future. At press time, ARB was trading above the 50-day Exponential Moving Average (EMA) on a daily time frame, indicating a potential shift in trend and growing bullish momentum in the short term. Supporting this structure is the accumulation data from CoinGlass. In the last 48 hours, ARB saw $2.2 million in Exchange Outflows, including a $2.57 million daily net outflows on the 1st of July. Source: CoinGlass This shift typically signals investor confidence—whales moving coins off exchanges for cold storage or long-term holds. Disclaimer: AMBCrypto's content is meant to be informational in nature and should not be interpreted as investment advice. Trading, buying or selling cryptocurrencies should be considered a high-risk investment and every reader is advised to do their own research before making any decisions. © 2025 AMBCrypto
--------------------------------------------------

Title: Nvidia stock price prediction 2025: Can NVDA hit $250 after 39% rally, or will China trade bans and AI chip rivals trigger a pullback?
URL: https://economictimes.indiatimes.com/news/international/us/nvidia-stock-price-prediction-2025-can-nvda-hit-250-after-39-rally-or-will-china-trade-bans-and-ai-chip-rivals-trigger-a-pullback/articleshow/122207809.cms
Time Published: 2025-07-02T13:35:26Z
Full Content:
(Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. (Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. Explore More Stories Calgary reintroduces fluoride to water supply after 14 year gap amid rising tooth decay Canadian tourist found dead on a Dominican Republic beach after mysterious 2 am walk Canada Day 2025: Wishes, images, themes, events and fireworks near you Carney dominates national polls according to Nanos Research, while Poilievre fights to re-enter Parliament Dinosaur in the space: Astronomers discover ancient galaxy untouched for 7 billion years Trade Minister Freeland announces removal of 53 federal trade barriers as Canada moves toward “one united economy” under Carney's vision How alleged sexual assault changed the life of five young Canadian hockey stars Alberta court halts ban on gender affirming care for youth as Premier vows to fight decision Health alert: Measles cases surge across BC Interior, flights, gatherings, and public exposed, health officials urge vaccinatio Canada kicks out Chinese surveillance giant Hikvision over national security threat Mass closures across for Canada Day on July 1: What’s open, what’s not, and how it’ll affect you 55 Canadians detained by ICE as Ottawa demands urgent answers after shocking death in US custody Canadians want to buy local this Canada Day, but rising prices are holding them back Xiaomi YU7: Tesla slayer or a victim of its own hype? INS Tamal: India’s latest stealth upgrade Dalai Lama asserts sole power over reincarnation DOGE eats Musk?: Trump threatens contract review Mamdani hits back at Trump over arrest threat Trump says US could reach trade deal with India ‘Everyone’s bill’: Trump lauds Big, Beautiful bill Chip Roy Explodes: Trump Bill blows up deficit Senate clears Trump’s 'Big Beautiful Bill' Noem visits ‘Alligator Alcatraz’ detention center Hot on Web In Case you missed it Top Searched Companies Top Calculators Top Definitions Most Searched IFSC Codes Top Story Listing Top Prime Articles Top Slideshow Private Companies Latest News Follow us on: Find this comment offensive? Choose your reason below and click on the Report button. This will alert our moderators to take action Reason for reporting: Your Reason has been Reported to the admin. Log In/Connect with: Will be displayed Will not be displayed Will be displayed Stories you might be interested in
--------------------------------------------------

Title: WPP (WPP) Slid on Weaker-Than-Expected Results
URL: https://finance.yahoo.com/news/wpp-wpp-slid-weaker-expected-124438769.html
Time Published: 2025-07-02T12:44:38Z
Description: Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Global Value Fund” first quarter 2025 investor letter. A copy of the...
--------------------------------------------------

Title: Here are the Reasons to Establish a Position in Alphabet (GOOGL)
URL: https://finance.yahoo.com/news/reasons-establish-position-alphabet-googl-113225555.html
Time Published: 2025-07-02T11:32:25Z
Description: Qualivian Investment Partners, an investment partnership focused on long-only public equities, released its Q1 2025 investor letter. A copy of the letter can...
--------------------------------------------------

Title: John Arnold with Dr. Peter Attia — The Greatest Energy Trader of All Time on Lessons Learned, Walking Away from Wall Street, and Reinventing Philanthropy (#818)
URL: https://tim.blog/2025/07/01/john-arnold/
Time Published: 2025-07-02T02:31:32Z
Full Content:
The Blog of Author Tim Ferriss Tim Ferriss is the author of five #1 New York Times bestsellers and host of The Tim Ferriss Show podcast. In this special episode, my friend—and fan-favorite guest—Dr. Peter Attia takes the mic as guest host. Peter sits down with legendary trader John Arnold, widely considered the greatest energy trader of all time. Today, through his foundation Arnold Ventures, John applies the same rigorous thinking to some of America’s toughest social challenges—criminal justice reform, healthcare policy, and K–12 education, to name just a few. This interview originally aired on Peter’s excellent podcast The Drive. You can check it out at PeterAttiaMD.com, or subscribe to The Drive wherever you get your podcasts. Please enjoy! Listen to the episode on Apple Podcasts, Spotify, Overcast, Podcast Addict, Pocket Casts, Castbox, YouTube Music, Amazon Music, Audible, or on your favorite podcast platform. This episode is brought to you by Vanta trusted compliance and security platform; Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating; and Wealthfront high-yield cash account. This episode is brought to you by Vanta! Vanta automates compliance for frameworks like SOC 2, ISO 27001, and HIPAA, making it simple and fast to get enterprise-grade compliant. Just like 10,000+ other companies that rely on Vanta, my friends at Duolingo and Ramp (a sponsor of this podcast and an ultra-fast growing company) both use Vanta to handle security compliance. It all adds up to impressive results: companies save up to 85% of costs, get compliant in weeks instead of months, and complete security questionnaires up to 5 times faster. So check out Vanta.com/Tim to see how Vanta can help you level up your security program. My listeners, that’s you, can get $1,000 off. This episode is brought to you by Wealthfront! Wealthfront is a financial services platform that offers services to help you save and invest your money. Right now, you can earn 4.00% APY—that’s the Annual Percentage Yield—with the Wealthfront Brokerage Cash Accoount. That’s nearly 10x more interest than if you left your money in a savings account at the average bank, with savings rates at 0.42%, according to FDIC.gov, as of 05/19/2025. It takes just a few minutes to sign up, and then you’ll immediately start earning 4.00% APY from program banks on your uninvested cash. And when new clients open an account today, they’ll get an extra $50 bonus with a deposit of $500 or more. Terms and Conditions apply. Visit Wealthfront.com/Tim to get started. Cash Account offered by Wealthfront Brokerage LLC, member FINRA/SIPC. Wealthfront is not a bank. The APY on cash deposits as of 04/30/2025, is representative, subject to change, and requires no minimum. Funds in the Cash Account are swept to program banks, where they earn a variable APY. Tim receives cash compensation from Wealthfront Brokerage for advertising and holds a non-controlling equity interest in the corporate parent of Wealthfront Brokerage. Tim and Wealthfront Brokerage have no other affiliation. Tim reflects his own opinions and Wealthfront does not endorse, sponsor, or promote them. See full disclosures here. This episode is brought to you by Eight Sleep. Temperature is one of the main causes of poor sleep, and heat is my personal nemesis. I’ve suffered for decades, tossing and turning, throwing blankets off, pulling them back on, and repeating ad nauseam. But a few years ago, I started using the Pod Cover, and it has transformed my sleep. Eight Sleep has launched their newest generation of the Pod: Pod 5 Ultra. It cools, it heats, and now it elevates, automatically. With the best temperature performance to date, Pod 5 Ultra ensures you and your partner stay cool in the heat and cozy warm in the cold. Plus, it automatically tracks your sleep time, snoring, sleep stages, and HRV, all with high precision. For example, their heart rate tracking is at an incredible 99% accuracy. Pod 5 Ultra also introduces an adjustable Base that fits between your mattress and your bed frame to add custom positions for the best sleeping experience. It also automatically reduces your snoring when detected. Add it easily to any bed. And for full coverage, you can include the Blanket, which uses the same technology as the Pod’s Cover to extend temperature regulation over your entire body.And now, listeners of The Tim Ferriss Show can get $350 off of the Pod 5 Ultra for a limited time! Click here to claim this deal and unlock your full potential through optimal sleep. What was your favorite quote or lesson from this episode? Please let me know in the comments. [00:00:00] Start.[00:05:37] Peter Attia’s intro: who is John Arnold?[00:08:38] John’s background, upbringing, and early entrepreneurial tendencies.[00:21:16] John’s time and rise at Enron.[00:33:40] Characteristics that made John an exceptional natural gas trader and how they translate to his philanthropic work.[00:41:10] The collapse of Enron.[00:46:46] The success of John’s hedge fund, and his early interest in philanthropy.[01:02:03] The infamous 2006 trade that brought down Amaranth Advisors.[01:08:28] John’s analytical prowess and emphasis on fundamentals.[01:15:13] The decision to become a full-time philanthropist and the founding of Arnold Ventures.[01:25:03] Education — John’s quest to fundamentally change K-12 education.[01:30:36] Strategic philanthropy — preventing problems by attacking root causes and creating structural change.[01:37:50] The criminal justice system — structural changes needed to address mass incarceration, policing practices, and recidivism.[01:55:07] Re-imagining prisons to reduce recidivism.[02:02:27] US health care policy — John’s focus on drug prices, and the severe consequences of not making system changes.[02:20:00] Climate change — the bipartisan role of John’s foundation.[02:23:52] Advice for young adults interested in philanthropy.[02:30:52] Parting thoughts. Who is John? Arnold Ventures “Our philanthropic intent is to give away the vast majority of our money during our lifetime.” An entrepreneur from a young age “I ended up spending a couple summers just full time on this baseball card, really geographic arbitrage and information arbitrage, that I would have a sense of who the best buyer was for every product.” Defining arbitrage— What he wanted to do after college “I was the guy that was trying to get out of there and into the game as quickly as possible. Every day I was at college, it was one less day that I had to be in the game.” What that meant to the industry: In 1995, there were 2 aspects to Enron’s business: 1 – The historical pipeline business 2 – A new “investment bank” side John first job at Enron “I found the perfect job for my skill set as my first job. And I think that’s pretty rare, and it happened by accident. I could have very easily ended up a mergers and acquisition investment banker at Merrill Lynch, but I ended up trading commodities at a relative upstart of a company that was just the perfect spot for my skill set.” How John rose so quickly through Enron Winter of 1996—“A whole new game” “I think it ended up being the downfall of the company as well, as there just wasn’t the controls on people who were given too much responsibility, too much of the company’s balance sheet to use without their adequate controls on it.” “The stress level was intense. I think I’m very good at handling stress, but the stress level was intense to a point of not being healthy.” How do many traders destress? Did John experience an “addiction” to the “high” of trading? What made John such an exceptional trader? Regarding emotional detachment— ⇒ There’s a saying in the investment world, “Fear and greed drives a lot of price trends in financial assets.” The confidence spectrum— How did these traits translate into John’s philanthropy work? “Everything we’re doing in the foundation is evidence-based, but the evidence is never perfect.” Book about the fall of Enron: The Smartest Guys in the Room Preceding Enron’s collapse… Bad decisions— When did John realize his career at Enron was going to be cut short? When John was still at Enron… How John grew Centaurus so successfully The synergy of market arbitrage plus speculative trading: The two strands of John’s hedge fund— 1) Providing liquidity and getting paid for the service of warehousing some risks, and 2) Speculative trading – Trying to make a call on where natural gas prices were going next The moment John realized he’d never have to worry about money again: When did John first start thinking about philanthropy? “I always recognized the limited social value of trading. I think there is a need for someone to provide risk warehousing and liquidity to markets, but trying to tell the story about how I was adding value or contributing to society was hard. And that always bothered me.” When John’s hedge fund started gaining major attention: John business was all about return (not fees from investors)— Background After 2005, two things happened in the industry— Amaranth’s position in 2006— So what happened in 2006? How John thought about the situation: John has a “third superpower”—an insatiable, bordering on pathological, obsession for knowing everything In his trading days… How did John make up for this informational disadvantage? “Our advantage was that we’re going to invest in the fundamentals more than anybody else is and then overlay that with some good trading.” 3 main reasons why trading natural gas was “easier” than oil: 1) It was this closed system —the molecules, for the most part, just stayed in North America 2) Deregulation got the pipelines out of the business of trading 3) Twice a year, there was a mechanism to get you back close to fair value Deciding to focus on philanthropy “I started thinking more about giving the money away than making more of it. That was really the signal to me that I want to be spending my time on the other side of the table and I’m physically and mentally, emotionally exhausted with trading natural gas.” A hard decision “When you’ve been playing in Vegas with the $25 table to go back down to the $5 table. It’s just not as emotionally interesting.” Summary of factors leading to the shutdown of his hedge fund— “These things came together and it still took me two years to make that call, that it’s time, it’s time to close this up and go find happiness somewhere else.” Skills in trading that translated to philanthropy: 1-Emotional temperament—not letting your feelings get in the way of what you’re doing 2-Having the right amount of confidence 3-An ability to become an expert in something in a relatively short period of time K-12 education — the first problem the foundation looked at deeply The questions John had about K-12 education: “[K-12] is just the most fundamental issue facing long-term health and viability of this country.” The theory of change that drives John’s work in K-12: The theory: Strong and robust systems of any kind have the attributes of biological evolution In public education— Arnold Foundation’s theory is that… If this theory works… What’s the role of philanthropy? Role for “strategic” philanthropy How challenging is doing this kind of strategic philanthropy? Example, the topic like preschool: In every area that John has researched, he finds the same thing— *One main insight from doing the deep digging: The question for the foundation became: What’s our role? Where could our dollars be most helpful? John’s frustration with trying to find the “right program” to fund really led him and the foundation down the path of—How do you change and improve the system and the incentives and the rules of a system rather than what’s the next program we can fund? When the criminal justice system got on John’s radar: “There is this natural impatience. But I think we’ve been smart enough to realize that it’s smarter to invest wisely tomorrow than do something that’s unlikely to have an impact today.” How criminal justice system is broken: John’s take on how we got to the current state of the criminal just system: Fast forward to today— Speculating on what accounted for the reduction is crime starting in the mid-90s What other factors could have accounted for the reduction in crime if not the increase in incarceration? Of all the mechanisms or tactics that would lead to an increase in incarceration, which of those were perhaps the most responsible for mass incarceration? How do we solve this problem? Is the role for philanthropy to try to address the questions of racism within law enforcement? For a long time, the focus has been on reducing crime rates with no regard for the secondary effects that the criminal justice system causes on these communities and families A big dilemma: Minority communities have felt both over-policed and under policed at the same time. Addressing the problem: Peter’s take on the prison system: John’s response: “The nature of prisons has to change. If you wait until the days someone’s released, that’s way too late.” The foundation’s work on re-imagining prisons The ROI case The values case How is John thinking about health policy in America? So where is John trying to apply his resources? The first area John wants to address is drug prices because it’s a topic with: The foundation is focused on creating a more rational system to price pharmaceuticals that— The political window: For politicians to consider health care policies— Peter’s rant on the US health care: ⇒ For more on the health care system and issues with drugs, see Peter’s interviews with Marty Makary and Katherine Eban Enormous health care spending—how can we change this? Without the greatest sovereign default on debt, what is it going to take to change this? The severe consequences of inflation “I want to help the world, I want to solve problems, but if the answer is just shovel more money at it, that’s not a sustainable answer in my mind.” John’s foundation is working on: How do we improve the system without spending more money? Optimistic about the future — Change happens slowly, then very quickly “You just don’t have that feedback mechanism in this work that you had in the [natural gas] market and the complete opposite end of the spectrum” John’s high level thoughts on climate change How will John’s foundation work on climate change? Where John thinks they can add value: Regarding his own kids— “Whenever you have that checkbook, people look at you differently, and treat you differently. . .because there is always something that they want funded. . .If somebody’s growing up in their teens and their 20s, and is looked at by the rest of the world as a checkbook first, I think that’s a very damaging way to grow up.” Advice to young adults with an interest in philanthropy: The Tim Ferriss Show is one of the most popular podcasts in the world with more than one billion downloads. It has been selected for "Best of Apple Podcasts" three times, it is often the #1 interview podcast across all of Apple Podcasts, and it's been ranked #1 out of 400,000+ podcasts on many occasions. To listen to any of the past episodes for free, check out this page. The Tim Ferriss Show is one of the most popular podcasts in the world with more than one billion downloads. It has been selected for "Best of Apple Podcasts" three times, it is often the #1 interview podcast across all of Apple Podcasts, and it's been ranked #1 out of 400,000+ podcasts on many occasions. To listen to any of the past episodes for free, check out this page. Δ Δ Comment Rules: Remember what Fonzie was like? Cool. That’s how we’re gonna be — cool. Critical is fine, but if you’re rude, we’ll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for adding to the conversation! (Thanks to Brian Oberkirch for the inspiration.) This site is an Amazon Associate and purchases through Amazon links may earn an affiliate commission.
--------------------------------------------------

Title: Here’s Why Qualivian Investment Partner Added Watsco (WSO) to Its Portfolio
URL: https://finance.yahoo.com/news/why-qualivian-investment-partner-added-123423592.html
Time Published: 2025-07-01T12:34:23Z
Description: Qualivian Investment Partners, an investment partnership focused on long-only public equities, released its Q1 2025 investor letter. A copy of the letter can...
--------------------------------------------------

Title: Qualivian Investment Partner Sold Its Stake in United Rentals (URI) in Q1
URL: https://finance.yahoo.com/news/qualivian-investment-partner-sold-stake-122921308.html
Time Published: 2025-07-01T12:29:21Z
Description: Qualivian Investment Partners, an investment partnership focused on long-only public equities, released its Q1 2025 investor letter. A copy of the letter can...
--------------------------------------------------

Title: Riverwater Partners Sustainable Value Strategy’s Top Contributor: Mr. Cooper (COOP)
URL: https://finance.yahoo.com/news/riverwater-partners-sustainable-value-strategy-115644304.html
Time Published: 2025-07-01T11:56:44Z
Description: Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q1 2025 investor letter. A copy of the letter can be...
--------------------------------------------------

Title: Decline in Cosmetic Sales Affected Coty (COTY) in Q1
URL: https://finance.yahoo.com/news/decline-cosmetic-sales-affected-coty-113322087.html
Time Published: 2025-07-01T11:33:22Z
Description: Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” first quarter 2025 investor letter...
--------------------------------------------------

Title: NVIDIA Corporation (NVDA) Set To Hit $4 Trillion Market Cap
URL: https://finance.yahoo.com/news/nvidia-corporation-nvda-set-hit-211114638.html
Time Published: 2025-06-30T21:11:14Z
Description: NVIDIA Corporation (NASDAQ:NVDA) is among the 13 Best Big Name Stocks to Buy Now. Two years after joining the $1 trillion club, the chipmaker is on the verge...
--------------------------------------------------

Title: NVIDIA Corporation (NVDA) Insiders Cash Out Over $1 Billion In Stock Amid Market Surge: Report
URL: https://finance.yahoo.com/news/nvidia-corporation-nvda-insiders-cash-210457901.html
Time Published: 2025-06-30T21:04:57Z
Description: NVIDIA Corporation (NASDAQ:NVDA) is among the Goldman Sachs Stock Portfolio: 10 Large-Cap Stocks To Buy. The company’s insiders have sold over $1 billion...
--------------------------------------------------

Title: This Defense Stock Could Be the Next Palantir. Should You Buy It Now?
URL: https://www.barchart.com/story/news/33128552/this-defense-stock-could-be-the-next-palantir-should-you-buy-it-now
Time Published: 2025-06-30T20:08:15Z
Description: As defense spending soars across the world, the path to further upside for this stock remains.
--------------------------------------------------

Title: 5 Dividend Stocks To Buy Now For July 2025
URL: https://www.forbes.com/sites/investor-hub/article/5-best-dividend-stocks-buy-july-2025/
Time Published: 2025-06-30T18:37:30Z
Full Content:
ByJason Kirsch ByJason Kirsch, Contributor. The combination of attractive yields, reasonable valuations, and strong dividend safety scores makes ... More this diversified selection an ideal choice for building a robust income-generating portfolio in the current market environment. The dividend investing landscape continues to evolve as we move through 2025, presenting both opportunities and challenges for income-focused investors. With the upward trend in interest rates stabilizing (and perhaps soon declining) and economic uncertainty persisting in various sectors, dividend stocks remain a cornerstone strategy for building wealth while generating steady cash flow. The current market environment has created compelling entry points across multiple industries, from energy infrastructure to consumer staples. This article examines five carefully selected dividend-paying stocks that offer attractive yields, strong fundamentals and the potential for long-term capital appreciation. Each selection has been evaluated based on dividend safety (according to the ratings of Dividend.com), business model sustainability, and current valuation metrics to provide readers with actionable investment opportunities for the remainder of 2025. The selection process for these dividend stocks involved a comprehensive analysis of multiple factors, beyond just yield percentage. Primary consideration was given to dividend safety scores (as scored by Dividend.com), which evaluate a company's ability to maintain and potentially grow its dividend payments over time. Companies with scores above 3.0 were prioritized, indicating a reasonable level of confidence in the sustainability of their dividends. Market capitalization, current valuation relative to analyst price targets and year-to-date performance were also critical factors in the evaluation process. Special attention was paid to companies trading below their recommended price targets, suggesting potential upside beyond the dividend yield. The final selections represent a diversified mix of sectors, including energy infrastructure, real estate, consumer goods, utilities and pharmaceuticals, providing investors with exposure to different economic drivers while maintaining focus on income generation. Enterprise Products Partners stands as one of North America's largest midstream energy companies, operating an extensive network of pipelines, storage facilities and processing plants across the United States. The master limited partnership structure provides tax advantages while focusing on the critical infrastructure that connects energy producers with end markets. Currently trading at $31.09 per share with a market capitalization of $67.50 billion, EPD represents a substantial player in the energy infrastructure space. The company's business model centers on fee-based contracts rather than commodity price exposure, providing more predictable cash flows compared to upstream energy companies. With a dividend safety score of 4.2, EPD demonstrates strong fundamentals supporting its generous 6.88% yield. The partnership has maintained its distribution for over 25 years, showcasing remarkable consistency even through challenging energy market cycles. Enterprise Products Partners offers compelling value at current levels, trading significantly above the analyst price recommendation of $25.77, yet still providing exceptional income potential. The 6.88% yield represents one of the highest sustainable yields available from a large-cap energy infrastructure company, supported by diversified cash flows from natural gas, crude oil and petrochemical transportation services. The company's strategic positioning benefits from North America's continued growth in energy production and the ongoing need for midstream infrastructure. Recent expansion projects and strategic acquisitions have strengthened EPD's competitive moat while providing additional growth catalysts. Despite modest year-to-date returns of 1.44%, the combination of high current income and potential for distribution growth makes EPD attractive for income-focused investors seeking energy sector exposure. Mid-America Apartment Communities operates as a real estate investment trust, specializing in multifamily residential properties across the Sun Belt region of the United States. With a market capitalization of $17.46 billion and a current share price of $147.46, MAA represents a significant player in the apartment rental market. The company's portfolio comprises high-quality apartment communities in growing metropolitan areas, which benefit from favorable demographic trends and regional economic expansion. The REIT structure requires MAA to distribute at least 90% of its taxable income to shareholders, supporting its current 4.11% dividend yield with a forward dividend of $6.06 per share. While the dividend safety score of 3.4 indicates moderate risk, the company's focus on Sunbelt markets, characterized by strong job growth and population migration, provides fundamental support for rental demand and pricing power. Mid-America Apartment Communities presents an attractive opportunity in the residential real estate sector, particularly given the ongoing housing shortage and demographic trends favoring rental properties. The company's geographic focus on high-growth Sunbelt markets positions it to benefit from continued population migration from higher-cost regions, supporting both occupancy rates and rental growth potential. Trading above the analyst price recommendation of $136.93, MAA's current valuation reflects market recognition of its quality portfolio and strategic positioning. Despite a modest year-to-date decline of 1.56%, the company's consistent dividend payments and exposure to essential housing needs provide defensive characteristics. The combination of steady income and potential for capital appreciation as interest rates stabilize makes MAA suitable for investors seeking real estate exposure with reliable dividend income. PepsiCo is among the world's largest food and beverage companies, operating iconic brands such as Pepsi, Frito-Lay, Tropicana and Quaker Oats. With a massive market capitalization of $179.68 billion and a current trading price of $128.22, PEP represents a blue-chip investment in the consumer staples sector with a global reach. The company's diversified portfolio spans beverages, snacks and food products, providing multiple revenue streams and geographic diversification. The dividend safety score of 3.7 reflects PEP's strong balance sheet and consistent cash generation capabilities, which support its current yield of 4.44% with a forward dividend of $5.69 per share. As a Dividend Aristocrat with over 50 years of consecutive dividend increases, PepsiCo demonstrates an exceptional commitment to returning capital to shareholders while investing in business growth and innovation. PepsiCo presents exceptional value at current levels, trading significantly below the analyst price recommendation of $181.54, suggesting substantial upside potential beyond the attractive dividend yield. The year-to-date decline of around 11% has created an opportunity to acquire shares of this high-quality consumer staples company at a discount to fair value estimates. The company's defensive business model provides stability during economic uncertainty, as consumers continue purchasing food and beverages regardless of economic conditions. Recent strategic initiatives focusing on healthier product offerings and sustainability align with evolving consumer preferences while supporting long-term growth prospects. The combination of a discounted valuation, reliable dividend growth history and defensive characteristics makes PEP particularly attractive for conservative dividend investors seeking quality at reasonable prices. UGI Corporation operates as a diversified energy company providing natural gas and electric utility services, propane distribution and energy marketing across the United States and internationally. With a market capitalization of $7.82 billion and a current share price of $36.05, UGI represents a mid-cap utility investment with both regulated and unregulated business segments. The company's operations span utility services in Pennsylvania, propane distribution through AmeriGas and international energy operations. The impressive dividend safety score of 4.4 reflects UGI's stable cash flows from regulated utility operations and established propane distribution network. Currently yielding 4.16% with a forward dividend of $1.50 per share, UGI offers an attractive income stream while maintaining financial flexibility for growth investments and infrastructure improvements. UGI Corporation has delivered exceptional performance with year-to-date returns of 32.09%, yet still offers compelling value for dividend-focused investors. The company's diversified business model provides multiple growth drivers, including regulated utility rate increases, expansion opportunities in propane distribution, and renewable energy initiatives. Trading above the analyst price recommendation of $28.28, UGI's recent performance reflects market recognition of its strategic positioning and execution capabilities. The utility sector's defensive characteristics, combined with UGI's growth initiatives in renewable energy and infrastructure modernization, provide both stability and upside potential. The strong dividend safety score and consistent payment history make UGI suitable for investors seeking utility sector exposure with above-average growth prospects. AbbVie operates as a global biopharmaceutical company, focusing on the development and commercialization of advanced therapies across immunology, oncology, neuroscience and other therapeutic areas. With a substantial market capitalization of $327.76 billion and current trading price of $186.79, ABBV represents one of the largest pharmaceutical companies globally. The company's portfolio includes blockbuster drugs such as Humira, Skyrizi and Rinvoq, generating substantial cash flows to support dividend payments and research and development investments. The dividend safety score of 4.3 reflects AbbVie's strong financial position and diversified revenue base, supporting its current yield of 3.51% with a forward dividend of $6.56 per share. Despite facing patent expirations on key products, the company's robust pipeline and strategic acquisitions provide confidence in long-term cash flow generation and dividend sustainability. AbbVie presents an attractive value proposition, trading near the analyst price recommendation of $189.65, with a solid year-to-date performance of 6.39%, demonstrating market confidence in the company's strategic direction. The pharmaceutical giant's focus on high-growth therapeutic areas and strong pipeline development provides multiple catalysts for future growth beyond current dividend income. The company's successful navigation of Humira's patent cliff, achieved through new product launches and strategic positioning, demonstrates management's ability to adapt to industry challenges. Recent acquisitions and pipeline developments in oncology and immunology support long-term growth prospects while maintaining the financial strength necessary for consistent dividend payments. The combination of current income, growth potential and defensive characteristics of the healthcare sector makes ABBV suitable for investors seeking pharmaceutical exposure with reliable dividend income. Bottom Line These five dividend stocks represent compelling opportunities across diverse sectors, each offering unique advantages for income-focused investors in July 2025. Enterprise Products Partners provides exceptional yield from energy infrastructure, while Mid-America Apartment Communities offers real estate exposure with Sunbelt growth potential. PepsiCo presents blue-chip quality at discounted valuations, UGI combines utility stability with growth initiatives, and AbbVie delivers pharmaceutical innovation with strong dividend coverage. The combination of attractive yields, reasonable valuations, and strong dividend safety scores makes this diversified selection an ideal choice for building a robust income-generating portfolio in the current market environment.
--------------------------------------------------

Title: 5 Top Undervalued Stocks To Buy For July 2025
URL: https://www.forbes.com/sites/investor-hub/article/best-undervalued-stocks-to-buy-july-2025/
Time Published: 2025-06-30T18:28:09Z
Full Content:
ByJason Kirsch ByJason Kirsch, Contributor. The combination of reasonable valuations, strong competitive positions and clear catalysts for ... More future value recognition makes this group particularly attractive for long-term investors willing to be patient while markets recognize their intrinsic worth. The stock market has always been a realm where patience meets opportunity, and July 2025 presents a particularly compelling landscape for value-oriented investors. While growth stocks continue to dominate headlines, a careful examination of market fundamentals reveals several high-quality companies trading at attractive valuations relative to their intrinsic worth. These opportunities often emerge when market sentiment temporarily overshadows solid business fundamentals, creating windows for astute investors to acquire shares of profitable enterprises at discounted prices. In this comprehensive analysis, we'll explore five exceptional companies that currently trade below their fair value, offering investors the potential for substantial returns as markets eventually recognize their true worth. Each selection represents a different sector and investment thesis, providing diversification opportunities while maintaining a focus on companies with strong competitive positions, healthy balance sheets and clear paths to future growth. These aren't speculative plays or turnaround stories; instead, they are established businesses that have temporarily fallen out of favor with the broader market. Selection methodology combines traditional value investing principles with modern financial analysis to identify companies trading below their intrinsic value. The primary screening criteria focused on companies with price-to-earnings ratios significantly below their historical averages and current share prices trading near or below key moving averages, indicating potential technical support levels. I specifically sought companies where the current stock price reflects pessimism that appears disconnected from underlying business performance. Beyond valuation metrics, each selected company demonstrates strong operational fundamentals, including consistent profitability, manageable debt levels and competitive advantages within their respective industries. Businesses with predictable cash flows, experienced management teams and clear catalysts that could drive future value recognition were prioritized. The analysis also considered macroeconomic factors, industry trends and company-specific developments that might influence near-term performance while maintaining focus on long-term value creation potential. Johnson & Johnson stands as one of the world's most diversified healthcare conglomerates, operating across three primary segments that have demonstrated remarkable resilience through various economic cycles. The company's pharmaceutical division generates the majority of revenue through innovative treatments in oncology, immunology and infectious diseases, while its medical devices segment serves hospitals and surgical centers globally. The consumer products division, though recently spun off, historically provided stable cash flows through trusted brands like Tylenol, Band-Aid and Neutrogena. Currently trading at approximately $152 per share with a market capitalization of $425 billion, JNJ operates in the healthcare sector, boasting a forward price-to-earnings ratio of 15.8, which is significantly below its five-year average of 18.2. The company maintains an impressive dividend track record, having increased payments for 62 consecutive years, which has earned it Dividend King status. With earnings per share of $10.15 and a robust pipeline of pharmaceutical products in development, Johnson & Johnson presents compelling value characteristics that have attracted long-term investors for decades. Johnson & Johnson's current valuation reflects temporary headwinds rather than fundamental deterioration in its business model. The stock trades near its 200-day moving average of $158, suggesting technical support at current levels, while the pharmaceutical pipeline continues to generate promising clinical trial results. Recent concerns about litigation costs and patent expirations have created selling pressure, but these challenges appear manageable given the company's financial strength and diversified revenue streams. The company's pharmaceutical division continues to launch innovative treatments, with several blockbuster drugs in late-stage development that are expected to drive significant revenue growth over the next five years. Management's focus on high-margin pharmaceutical products, combined with strategic acquisitions and partnerships, positions JNJ to capitalize on demographic trends, including aging populations and increased global healthcare spending. The current dividend yield of 3.2% offers an attractive income while investors await the market's recognition of the company's intrinsic value, making it an ideal core holding for value-oriented portfolios. Berkshire Hathaway represents Warren Buffett's masterpiece in value creation, operating as a diversified conglomerate with wholly owned subsidiaries spanning the insurance, energy, manufacturing and retail sectors. The company's insurance operations, including GEICO and Berkshire Hathaway Reinsurance Group, generate substantial float that management deploys into profitable investments and acquisitions. Beyond insurance, Berkshire owns iconic American businesses, including BNSF Railway, Berkshire Hathaway Energy and numerous manufacturing companies that benefit from strong competitive positions and experienced management teams. Trading at approximately $485 per share for Class B shares, Berkshire Hathaway maintains a price-to-earnings ratio of 17.1, which is reasonable for a company of its quality and diversification. The conglomerate generates earnings per share of $22.80 across its various operating segments, though this figure can fluctuate significantly based on investment gains and losses. Unlike most large corporations, Berkshire pays no dividend; instead, it reinvests all profits in growing the business and building shareholder value through capital appreciation and strategic acquisitions. Berkshire Hathaway's current valuation appears attractive relative to the sum of its parts, with the stock trading below its intrinsic value as calculated by many analysts who closely follow the company. The shares recently touched their 50-day moving average of $385, providing a potential entry point for investors seeking exposure to Buffett's investment acumen and the company's diversified business model. Market concerns about succession planning and the advanced age of key leadership have created temporary selling pressure, but these concerns overlook the deep bench of talented managers throughout the organization. The company's massive cash position, currently exceeding $150 billion, provides tremendous flexibility for opportunistic investments and acquisitions during market downturns. Berkshire's operating businesses continue to generate strong cash flows, while the investment portfolio benefits from positions in high-quality companies like Apple, Bank of America and Coca-Cola. The combination of defensive characteristics during economic uncertainty and offensive capabilities during market dislocations makes Berkshire Hathaway an exceptional value proposition for investors seeking long-term wealth preservation and growth. Pfizer Inc. operates as one of the world's largest pharmaceutical companies, developing and manufacturing prescription medicines and vaccines that address critical health needs across diverse therapeutic areas. The company's portfolio encompasses treatments for oncology, rare diseases, inflammation and infectious diseases, with a particular strength in areas that require significant research and development investments. Pfizer's recent success with COVID-19 vaccines and treatments has demonstrated its ability to develop and commercialize innovative therapies rapidly. However, this success has also created challenging comparisons as pandemic-related revenues normalize. Currently priced at approximately $24 per share, with a market capitalization of $137 billion, Pfizer trades in the healthcare sector, boasting a forward price-to-earnings ratio of 11.2, which is well below historical averages and those of its peer companies. The stock offers an attractive dividend yield of 5.8%, supported by earnings per share of $2.84 and a commitment to returning capital to shareholders through both dividends and share repurchases. The company's extensive pipeline includes numerous late-stage candidates that could drive future growth, while its established products continue to generate substantial cash flows to fund research and development activities. Pfizer's current valuation reflects excessive pessimism about the company's post-pandemic prospects, creating an attractive entry point for value investors willing to look beyond near-term headwinds. The stock trades near its 52-week low and below its 200-day moving average of $35, suggesting that negative sentiment has been fully reflected in the share price. While COVID-related revenues will inevitably decline, the company's underlying pharmaceutical business remains robust, with several promising drug candidates approaching commercialization that could offset this revenue decline. The pharmaceutical industry's defensive characteristics become particularly valuable during economic uncertainty, as healthcare spending tends to remain stable regardless of broader economic conditions. Pfizer's strong balance sheet, experienced management team, and commitment to innovation position the company to capitalize on demographic trends including aging populations and increased prevalence of chronic diseases. The generous dividend yield offers an attractive income while investors await the market's recognition of Pfizer's diversified pharmaceutical portfolio and promising pipeline developments. Intel Corporation is a pioneer in the semiconductor industry, designing and manufacturing microprocessors and related technologies that power personal computers, data centers and emerging applications, including artificial intelligence and autonomous vehicles. The company's dominant position in central processing units has faced increased competition in recent years, particularly from Advanced Micro Devices and companies developing ARM-based processors, forcing Intel to invest heavily in manufacturing capabilities and product development. Despite these challenges, Intel maintains significant competitive advantages, including advanced manufacturing processes, extensive intellectual property portfolios and long-standing relationships with major technology companies. Trading at approximately $22 per share with a market capitalization of $195 billion, Intel operates in the technology sector, boasting a forward price-to-earnings ratio of 9.8, which represents a significant discount to its historical valuations and those of many of its technology peers. The company generates earnings per share of $4.92 while maintaining a dividend yield of 2.1%, demonstrating management's confidence in future cash flow generation. Intel's substantial investments in new manufacturing facilities and research and development activities position the company to compete effectively in next-generation semiconductor technologies. However, these investments have put pressure on near-term profitability. Intel's current valuation appears to reflect worst-case scenarios regarding the company's competitive position, creating potential upside for investors willing to bet on the company's turnaround efforts. The stock trades below its 200-day moving average of $46, indicating technical weakness that may have created an attractive entry point for long-term investors. Recent management changes and strategic initiatives, including significant investments in manufacturing capacity and partnerships with government entities, indicate that Intel is taking the necessary steps to address competitive challenges and capitalize on the growing demand for semiconductors. The global semiconductor shortage and increasing digitization trends support long-term demand for Intel's products, while government initiatives to strengthen domestic semiconductor manufacturing provide additional tailwinds. Intel's foundry services business represents a significant growth opportunity as companies seek alternatives to Asian manufacturing, particularly given geopolitical tensions and supply chain concerns. The combination of an attractive valuation, a defensive dividend yield and potential catalysts from new product launches and manufacturing investments makes Intel a compelling value proposition for patient investors willing to wait for the company's strategic initiatives to yield results. The Coca-Cola Company operates as the world's largest beverage company, manufacturing and distributing non-alcoholic beverages across more than 200 countries and territories through an extensive network of bottling partners and distributors. The company's portfolio includes iconic brands such as Coca-Cola, Sprite, Fanta and Dasani, as well as newer additions in categories including energy drinks, sports beverages and premium waters. Coca-Cola's business model focuses on concentrate production and brand marketing, while bottling partners handle manufacturing and distribution, creating an asset-light structure that generates attractive returns on invested capital. Currently valued at approximately $69 per share with a market capitalization of $300 billion, Coca-Cola operates in the consumer staples sector with a forward price-to-earnings ratio of 28.2, which is reasonable for a company with such strong brand recognition and global reach. The stock yields $2.69 per share and offers a dividend yield of 2.9%, supported by 62 consecutive years of dividend increases that have made Coca-Cola a favorite among income-focused investors. The company's global presence and diverse product portfolio provide natural hedges against regional economic fluctuations and changing consumer preferences. Coca-Cola's current trading level near $69 represents attractive value for a company with such enduring competitive advantages and predictable cash flows. The stock recently found support at its 100-day moving average of $63, suggesting technical strength despite broader market volatility. While concerns about health consciousness and sugar consumption have pressured beverage companies, Coca-Cola has successfully diversified its portfolio to include low-calorie and no-calorie options that address changing consumer preferences without sacrificing brand loyalty or pricing power. The company's global footprint presents significant opportunities for growth in emerging markets, where rising incomes and urbanization are driving increased demand for beverages. Coca-Cola's unmatched distribution network and brand recognition create substantial barriers to entry, protecting its market share and pricing power across diverse geographic markets. The reliable dividend growth history, combined with the company's ability to generate consistent cash flows regardless of economic conditions, makes Coca-Cola an ideal core holding for investors seeking stability and income in uncertain market environments. Bottom Line These five undervalued stocks represent compelling opportunities for investors seeking quality companies at attractive prices in July 2025. Each selection offers a different risk-reward profile and sector exposure, ranging from Johnson & Johnson's healthcare stability to Intel's technology turnaround potential. The combination of reasonable valuations, strong competitive positions and clear catalysts for future value recognition makes this group particularly attractive for long-term investors willing to be patient while markets recognize their intrinsic worth. While short-term volatility remains possible, the fundamental strength of these businesses, combined with their current attractive valuations, suggests significant upside potential for investors who can maintain a long-term perspective.
--------------------------------------------------

Title: These 5 Stocks Will Replace Your Job
URL: https://finance.yahoo.com/news/5-stocks-replace-job-162235786.html
Time Published: 2025-06-30T16:22:35Z
Description: Back in 1999, when I enlisted in the Marine Corps, my base pay started at less than $1,000 a month. Even after four years and a promotion to corporal, I was ...
--------------------------------------------------

Title: Taiwan Semiconductor Manufacturing Company Limited (TSM) Fell in Q1 Due to Concerns in AI Semis Landscape
URL: https://finance.yahoo.com/news/taiwan-semiconductor-manufacturing-company-limited-133802438.html
Time Published: 2025-06-30T13:38:02Z
Description: Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” first quarter 2025 investor letter...
--------------------------------------------------

Title: Here’s Riverwater Partners Small Cap Strategy’s Investment Thesis for Bowhead Specialty Holdings (BOW)
URL: https://finance.yahoo.com/news/riverwater-partners-small-cap-strategy-123151691.html
Time Published: 2025-06-30T12:31:51Z
Description: Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q1 2025 investor letter. A copy of the letter can be downloaded here...
--------------------------------------------------

Title: Accenture plc (ACN) Declined due to Investors’ Concerns Amid Heightened Global Uncertainty
URL: https://finance.yahoo.com/news/accenture-plc-acn-declined-due-115205959.html
Time Published: 2025-06-30T11:52:05Z
Description: Aristotle Capital Management, LLC, an investment management company, released its “International Equity Strategy” first quarter 2025 investor letter. A copy ...
--------------------------------------------------

Title: Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth
URL: https://finance.yahoo.com/news/concerns-rise-over-exact-sciences-113511462.html
Time Published: 2025-06-30T11:35:11Z
Description: Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter...
--------------------------------------------------

Title: Parnassus Growth Equity Fund Sold Its Stake in Adyen N.V. (ADYEY)
URL: https://finance.yahoo.com/news/parnassus-growth-equity-fund-sold-113022640.html
Time Published: 2025-06-30T11:30:22Z
Description: Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter...
--------------------------------------------------

Title: At least 10 dead in massive reactor blast at Sigachi Industries unit in Telangana’s Pashamylaram
URL: https://economictimes.indiatimes.com/news/india/at-least-10-dead-after-fire-at-sigachi-chemical-plant-in-indias-telangana-media-reports-say/articleshow/122155478.cms
Time Published: 2025-06-30T07:28:54Z
Full Content:
(Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online. (Catch all the Business News, Breaking News, Budget 2025 Events and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online. Zepto has slowed, and Aadit Palicha needs more than a big fund raise to fix it Drones have become a winning strategy in war; can they be in investing? Punit Goenka reloads Zee with Bullet and OTT focus. Can he beat mighty rivals? Profits plenty, prices attractive, still PSU stocks languish. Why? Stock Radar: Indus Tower stock breaks out from Symmetrical Triangle pattern; could hit fresh 52-week high – check target & stop loss Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41% Sudhanshu Trivedi hits out at Tejashwi Yadav, INDIA Bloc over Waqf Law Iran cleric issues fatwa against Trump & Netanyahu Mizoram's capital Aizawl to join the Railway network Monsoon covers entire India, IMD issues ‘red alert’ 4th Day of Puri’s Jagannath Rath Yatra Why Mahua is furious at party colleagues Madan, Kalyan IAEA chief's chilling warning: ‘Iran could enrich…’ Emergency did not just kill democracy..: PM Modi 'Big beautiful bill': US Senate clears Trump's ambitious bill Puri Stampede: Three dead, several injured Hot on Web In Case you missed it Top Searched Companies Top Calculators Top Slideshow Top Prime Articles Top Definitions Most Searched IFSC Codes Top Story Listing Private Companies Latest News Follow us on: Find this comment offensive? Choose your reason below and click on the Report button. This will alert our moderators to take action Reason for reporting: Your Reason has been Reported to the admin. Log In/Connect with: Will be displayed Will not be displayed Will be displayed Worry not. You’re just a step away. It seems like you're already an ETPrime member with Login using your ET Prime credentials to enjoy all member benefits Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits. Big Price Drop! Flat 40% Off Offer Exclusively For You Save up to Rs. 700/- ON ET PRIME MEMBERSHIP Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Offer Exclusively For You Get Flat 40% Off Then ₹ 1749 for 1 year Offer Exclusively For You ET Prime at ₹ 49 for 1 month Then ₹ 1749 for 1 year Special Offer Get flat 40% off on ETPrime What’s Included with ETPrime Membership Trump temper on H-1B visas is forcing Indians to do these things to stay put in US What Adani’s US indictment means for India Inc’s overseas fundraising Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer. Will China’s dollar bond sale in Saudi Arabia trump the US in financial world? Huawei launches its own OS to compete with Google and Apple. But can it win beyond China? The problem with lab grown diamonds Why a falling rupee is a better option for the economy A list of top 20 momentum stocks that have delivered massive returns in one year Investment Ideas Grow your wealth with stock ideas & sectoral trends. Stock Reports Plus Buy low & sell high with access to Stock Score, Upside potential & more. BigBull Porfolio Get to know where the market bulls are investing to identify the right stocks. Stock Analyzer Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks. Market Mood Analyze the market sentiments & identify the trend reversal for strategic decisions. Stock Talk Live at 9 AM Daily Ask your stock queries & get assured replies by ET appointed, SEBI registered experts. ePaper - Print View Read the PDF version of ET newspaper. Download & access it offline anytime. ePaper - Digital View Read your daily newspaper in Digital View & get it delivered to your inbox everyday. Wealth Edition Manage your money efficiently with this weekly money management guide. TOI ePaper Read the PDF version of TOI newspaper. Download & access it offline anytime. Deep Explainers Explore the In-depth explanation of complex topics for everyday life decisions. Health+ Stories Get fitter with daily health insights committed to your well-being. Personal Finance+ Stories Manage your wealth better with in-depth insights & updates on finance. New York Times Exclusives Stay globally informed with exclusive story from New York Times. TimesPrime Subscription Access 20+ premium subscriptions like Spotify, Amazon Prime & more. Docubay Subscription Stream new documentaries from all across the world every day. Leadership | Entrepreneurship People | Culture Leadership | Entrepreneurship People | Culture Leadership | Entrepreneurship People | Culture Leadership | Entrepreneurship People | Culture Leadership | Entrepreneurship People | Culture Stories you might be interested in
--------------------------------------------------